14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $143.51 $159.34 Tuesday, 23rd Apr 2024 ALNY stock ended at $146.07. This is 0.192% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 3.20% from a day low at $145.61 to a day high of $150.27.
90 days $143.51 $191.72
52 weeks $143.51 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Oct 23, 2023 $161.57 $163.54 $160.46 $162.00 339 924
Oct 20, 2023 $161.33 $163.52 $159.50 $161.79 731 932
Oct 19, 2023 $165.30 $165.68 $160.44 $160.50 683 798
Oct 18, 2023 $163.67 $166.60 $162.47 $165.08 487 283
Oct 17, 2023 $166.45 $170.38 $164.94 $165.98 656 292
Oct 16, 2023 $167.94 $169.26 $165.02 $167.25 521 961
Oct 13, 2023 $165.41 $169.97 $163.84 $168.12 520 395
Oct 12, 2023 $167.08 $168.13 $164.02 $165.29 779 650
Oct 11, 2023 $167.10 $169.38 $166.10 $167.82 757 884
Oct 10, 2023 $169.00 $170.79 $165.98 $169.06 884 934
Oct 09, 2023 $169.73 $173.30 $159.47 $168.32 1 514 439
Oct 06, 2023 $178.42 $180.81 $176.74 $176.92 431 029
Oct 05, 2023 $167.92 $178.97 $167.92 $178.71 549 902
Oct 04, 2023 $172.52 $172.52 $167.40 $169.17 654 073
Oct 03, 2023 $178.17 $179.77 $172.51 $172.91 557 849
Oct 02, 2023 $177.31 $179.29 $176.00 $178.96 615 552
Sep 29, 2023 $175.74 $177.85 $174.07 $177.10 733 759
Sep 28, 2023 $176.32 $178.24 $173.90 $174.03 359 341
Sep 27, 2023 $177.18 $178.55 $171.66 $176.86 511 654
Sep 26, 2023 $171.01 $175.41 $170.06 $175.05 570 545
Sep 25, 2023 $170.93 $172.31 $168.65 $170.77 458 730
Sep 22, 2023 $173.85 $174.51 $169.85 $171.55 672 287
Sep 21, 2023 $174.47 $175.39 $171.11 $173.85 674 376
Sep 20, 2023 $176.00 $179.49 $174.46 $175.52 565 311
Sep 19, 2023 $179.02 $180.17 $175.42 $175.66 608 890
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT